Literature DB >> 12088726

Dual SPECT of dopamine system using [99mTc]TRODAT-1 and [123I]IBZM in normal and 6-OHDA-lesioned formosan rock monkeys.

Kuo-Hsing Ma1, Wen-Sheng Huang, Chien-Hsing Chen, Shin-Zong Lin, Shiaw-Pyng Wey, Gann Ting, Shwun-De Wang, Hwan-Wun Liu, Jiang-Chuan Liu.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by a severe loss of the dopaminergic neurons in the substantia nigra pars compacta. In this study, we evaluated pre- and post-synaptic binding sites of the dopamine system in three normal and one parkinsonian monkeys using simultaneous [99mTc]TRODAT-1 and [123I]IBZM imaging. The parkinsonian monkey was induced by injecting 6-hydroxydopamine (6-OHDA) bilaterally into the medial forebrain bundle under MRI guidance. [99mTc]TRODAT-1 (targeting dopamine transporters) and [123I]IBZM (targeting D(2)/D(3) receptors) were administered almost simultaneously and the SPECT images were acquired over 4 h using a dual-headed gamma camera equipped with ultra-high resolution fan-beam collimators. Data were obtained using energy window of 15% centered on 140 keV for 99mTc in conjunction with 10% asymmetric energy window in a lower bound at 159 keV for 123I. Single SPECT studies of [99mTc]TRODAT-1 and [123I]IBZM were also performed. We found a comparable image quality and uptake ratios between single- and dual-isotope studies. There are higher TRODAT-1 uptakes in the control monkeys than the 6-OHDA-lesioned monkey. The uptake of [123I] IBZM showed no significant difference between controls and 6-OHDA-lesioned monkey. Our results suggest that dual isotope imaging using [99mTc]TRODAT-1 and [123I]IBZM may be a useful means in evaluating the changes of both pre- and post-synaptic dopamine system in a primate model of parkinsonism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088726     DOI: 10.1016/s0969-8051(02)00303-7

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  8 in total

1.  Quantitative evaluation of simultaneous reconstruction with model-based crosstalk compensation for 99mTc/123I dual-isotope simultaneous acquisition brain SPECT.

Authors:  Yong Du; Eric C Frey
Journal:  Med Phys       Date:  2009-06       Impact factor: 4.071

2.  Dual-isotope SPECT imaging of striatal dopamine: a comparative study between never-treated and haloperidol-treated first-episode schizophrenic patients.

Authors:  G J E Schmitt; S Dresel; T Frodl; C la Fougère; R Boerner; K Hahn; H-J Möller; E M Meisenzahl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11-13       Impact factor: 5.270

Review 3.  Toxin-induced models of Parkinson's disease.

Authors:  Jordi Bové; Delphine Prou; Céline Perier; Serge Przedborski
Journal:  NeuroRx       Date:  2005-07

4.  Age-related decline in motor behavior and striatal dopamine transporter in cynomolgus monkeys.

Authors:  Feng Yue; Sien Zeng; Di Wu; Deqiao Yi; Y Alex Zhang; Piu Chan
Journal:  J Neural Transm (Vienna)       Date:  2012-02-11       Impact factor: 3.575

5.  Simultaneous [99mTc]TRODAT-1 and [123I]ADAM brain SPECT in nonhuman primates.

Authors:  Kuo-Hsing Ma; Jong-Kang Lee; San-Yuan Huang; Chin-Bin Yeh; Yi-Chun Shen; Lie-Hang Shen; Chia-Chieh Chen; Ren-Shyan Liu; Jiang-Chuan Liu; Wen-Sheng Huang
Journal:  Mol Imaging Biol       Date:  2009-02-19       Impact factor: 3.488

Review 6.  SPECT molecular imaging in Parkinson's disease.

Authors:  Ling Wang; Qi Zhang; Huanbin Li; Hong Zhang
Journal:  J Biomed Biotechnol       Date:  2012-03-24

7.  Synthesis, Radiolabeling, and Preliminary in vivo Evaluation of [68Ga] IPCAT-NOTA as an Imaging Agent for Dopamine Transporter.

Authors:  Shiou-Shiow Farn; Kang-Wei Chang; Wan-Chi Lin; Hung-Man Yu; Kun-Liang Lin; Yu-Chin Tseng; Yu Chang; Chung-Shan Yu; Wuu-Jyh Lin
Journal:  Drug Des Devel Ther       Date:  2021-06-17       Impact factor: 4.162

Review 8.  The role of preclinical SPECT in oncological and neurological research in combination with either CT or MRI.

Authors:  Monique R Bernsen; Pieter E B Vaissier; Roel Van Holen; Jan Booij; Freek J Beekman; Marion de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05       Impact factor: 9.236

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.